Skip to search formSkip to main contentSkip to account menu

2-aza-2-dihydrosqualene

Known as: 2-aza-2,3-dihydrosqualene, 4,8,12,16,20-Docosapentaen-1-amine, N,N,4,8,13,17,21-heptamethyl-, (all-E)- 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Squalene
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
Preliminary screening of some squalenoid derivatives for toxicity towards dermatophytes
Summary. We report a preliminary study of the in vitro anti‐dermatophyte activity of six squalenoid derivatives that inhibit 2,3… 
1994
1994
Pharmacokinetic and biodistribution in mice of the hypocholesterolemic agent 2-aza-2,3-dihydrosqualene.
1986
1986
Inhibition of fungal and mammalian sterol biosynthesis by 2‐aza‐2,3‐dihydrosqualene
1986
1986
Inhibition of cholesterol biosynthesis in 3T3 fibroblasts by 2-aza-2,3-dihydrosqualene, a rationally designed 2,3-oxidosqualene cyclase inhibitor.
1983
1983
Inhibition of 2,3-oxidosqualene: beta-amyrin-cyclase, S-adenosyl-L-methionine: cycloartenol C-24-methyltransferase and cycloeucalenol: obtusifoliol isomerase by rationally designed molecules…
25-Azacycloartanol (I), 2-aza-2-dihydrosqualene (II) and Tridemorph (2,6-dimethyl-N-tridecylmorpholine) (III) are potent… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)